Zobrazeno 1 - 10
of 329
pro vyhledávání: '"Robert B. Livingston"'
Autor:
David A. Mankoff, Kenneth A. Krohn, Jeanne M. Link, Philip H. Petra, Robert B. Livingston, Thomas J. Lawton, Georgiana K. Ellis, Jennifer M. Specht, Julie R. Gralow, Erin K. Schubert, Lanell M. Peterson, Brenda F. Kurland, Hannah M. Linden
Purpose: To determine, by molecular imaging, how in vivo pharmacodynamics of estrogen-estrogen receptor (ER) binding differ between types of standard endocrine therapy.Experimental Design: The ER has been a highly successful target for breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223b35d88cbc7b10d10f0100295d7c2e
https://doi.org/10.1158/1078-0432.c.6519107
https://doi.org/10.1158/1078-0432.c.6519107
Autor:
David A. Mankoff, Kenneth A. Krohn, Jeanne M. Link, Philip H. Petra, Robert B. Livingston, Thomas J. Lawton, Georgiana K. Ellis, Jennifer M. Specht, Julie R. Gralow, Erin K. Schubert, Lanell M. Peterson, Brenda F. Kurland, Hannah M. Linden
PDF file - 85K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb0f3cbc34fdddf1f57b60213116294
https://doi.org/10.1158/1078-0432.22442366
https://doi.org/10.1158/1078-0432.22442366
Publikováno v:
Academy of Management Journal. 64:1873-1900
One important benefit of teamwork is the exchange and integration of diverse knowledge, experience, and opinions group members bring to the table. However, demographic attributes, such as race, gen...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74a00388c160d4084b707e5db2a05c57
https://doi.org/10.5465/amj.2017.1507
https://doi.org/10.5465/amj.2017.1507
Publikováno v:
Journal of Cancer, Vol 4, Iss 2, Pp 104-116 (2013)
Background: Inflammatory breast cancer (IBC) is a rare, highly aggressive form of breast cancer. The mechanism of IBC carcinogenesis remains unknown. We sought to evaluate potential genetic risk factors for IBC and whether or not the IBC cell lines S
Externí odkaz:
https://doaj.org/article/6d8315dee67749dea8d2c8bd9ca253db
Autor:
Mark Clemons, Jieling L M'iao, Jeffrey S. Abrams, Daniel F. Hayes, Helen K. Chew, J. Margolis, Elizabeth Claire Dees, Kim Z Dammann, Gabriel N. Hortobagyi, William E. Barlow, Catherine Van Poznak, Anthony D. Elias, Mark M. Schubert, Carla I. Falkson, Robert B. Livingston, Danika L. Lew, Shaker R. Dakhil, James N. Ingle, Michael J. Messino, Alexander H.G. Paterson, Dawn L. Hershman, Julie R. Gralow, Alison Stopeck
Publikováno v:
J Natl Cancer Inst
Background Adjuvant bisphosphonates, when given in a low-estrogen environment, can decrease breast cancer recurrence and death. Treatment guidelines include recommendations for adjuvant bisphosphonates in postmenopausal patients. SWOG/Alliance/Canadi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69138842205f645fc6822b6f6d2cc0c6
https://doi.org/10.1093/jnci/djz215
https://doi.org/10.1093/jnci/djz215
Autor:
Akila Raoul, Elias Obeid, Olufunmilayo I. Olopade, Mary Claire King, Marcio Debiasi, Marion S. Verp, Kristen Danielle Whitaker, Jeffrey Mueller, Xiaoming Wang, Yonglan Zheng, Fang Liu, Iris L. Romero, Angela R. Bradbury, Galina Khramtsova, Jane E. Churpek, Robert B. Livingston, Kirti Kulkarni, David V Schacht, Colin C. Pritchard, Susan Hong, Hongyuan Cao, Tom Walsh, Rodrigo Santa Cruz Guindalini, Nora Jaskowiak, Gregory S. Karczmar, Hiroyuki Abe, Deepa Sheth, Dezheng Huo, Toshio F. Yoshimatsu, Gillian M. Newstead
Publikováno v:
ResearcherID
Purpose: To establish a cohort of high-risk women undergoing intensive surveillance for breast cancer. Experimental Design: We performed dynamic contrast-enhanced MRI every 6 months in conjunction with annual mammography (MG). Eligible participants h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d887dda88d4923b42d7b995fdf0adda
https://doi.org/10.1158/1078-0432.ccr-18-0200
https://doi.org/10.1158/1078-0432.ccr-18-0200
Autor:
Steven Shak, Peter M. Ravdin, Reshma Jagsi, Robert B. Livingston, Thomas A. Buchholz, Wendy A. Woodward, Daniel F. Hayes, William E. Barlow, James N. Ingle, Gabriel N. Hortobagyi, Debasish Tripathy, Kathy S. Albain, Julie R. Gralow, C. Kent Osborne, Tari A. King, Nancy E. Davidson, Timothy J. Whelan, Frederick L. Baehner
Publikováno v:
JAMA Oncol
Importance The 21-gene assay recurrence score is increasingly used to personalize treatment recommendations for systemic therapy in postmenopausal women with estrogen receptor (ER)– or progesterone receptor (PR)–positive, node-positive breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4814e03b9ce9ed7540df2e86f005f69
https://pubmed.ncbi.nlm.nih.gov/31917424
https://pubmed.ncbi.nlm.nih.gov/31917424
Autor:
Victor J. Gonzalez, Rajayogesh Davuluri, Robert B. Livingston, Uma Goyal, Justin Famoso, Pavani Chalasani, Lauren LeBeau, Tijana Skrepnik, Rebecca K. Viscusi, Michele B. Ley
Publikováno v:
Oncomedicine. 2:61-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a21e659b1414e055c85b2e045060cf0
https://doi.org/10.7150/oncm.17910
https://doi.org/10.7150/oncm.17910
Autor:
Rita S. Mehta, Danika Lew, William E. Barlow, Shaker R. Dakhil, Julie Gralow, Gabriel N. Hortobagyi, Hannah M. Linden, Daniel F. Hayes, Theodore A. Vandenberg, KS Albain, Robert B. Livingston, NL Tirumali
Publikováno v:
Cancer Research. 78:PD5-07
Background: Anastrozole depletes estrogen via aromatase inhibition and fulvestrant binds and degrades estrogen receptor. In a Phase III trial we compared the concurrent use of these agents to anastrozole alone or sequential anastrozole and fulvestran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cd38538245bed3e831bbef5bf66f073
https://doi.org/10.1158/1538-7445.sabcs17-pd5-07
https://doi.org/10.1158/1538-7445.sabcs17-pd5-07
Autor:
Shaker R. Dakhil, Gabriel N. Hortobagyi, Theodore A. Vandenberg, Hannah M. Linden, William E. Barlow, Nagendra R. Tirumali, Daniel F. Hayes, Kathy S. Albain, Rita S. Mehta, Danika L. Lew, Julie Gralow, Robert B. Livingston
Publikováno v:
The New England journal of medicine, vol 380, iss 13
BackgroundWe previously reported prolonged progression-free survival and marginally prolonged overall survival among postmenopausal patients with hormone receptor-positive metastatic breast cancer who had been randomly assigned to receive the aromata
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff80c34c37d5ac1f03bd30d5444b4d7
https://pubmed.ncbi.nlm.nih.gov/31167077
https://pubmed.ncbi.nlm.nih.gov/31167077